ArticleResearch square2023

Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer.

Marcelo Sobral-Leite et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.